Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

Bari 11 trials 4 recruiting

11 Registered trials

4 Currently recruiting

Organisation

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

Location

Bari, Italy

Identifier

ORL-000007840

Address

Piazza Giulio Cesare 11, Italy

Departments

DIPARTIMENTO DELL'EMERGENZA E DEI TRAPIANTI DI ORGANI (D.E.T.O.)
ematologia
Ematologia con Trapianto Universitaria
Hematology and Stem Cell Transplantation Unit
Nephrology
Pediatria ad indirizzo oncoematologico
U.O. Ematologia con Trapianto

Clinical trials at this site (11)

Search interface

TALIM study, for the treatment of patients affected by persisent or recurrent Multiple Myeloma with the drug teclistamab and infusions of ly… Pending

2025-521827-61-00 refractory/relapsed multiple myeloma 4
Study to treat adult patients with BCR-ABL1+ Chronic Myeloid Leukemia with Asciminib as single agent or in combination with nilotinib:a GIME… Recruiting

2024-512696-12-00 BCR-ABL1+ Chronic Myeloid Leukemia 4 2025-06-24
A Study to Evaluate the Efficacy and Safety of XyloCore, a Glucose Sparing Experimental Solution, for Peritoneal Dialysis (ELIXIR) Recruiting

2024-513562-19-00 End-Stage Kidney Disease 5 2023-08-30
First-line combination of Bcl-2 inhibitor and monoclonal antibody followed by administration of Bcl-2 inhibitor alone or combination of Bcl-… Recruiting

2023-510431-11-00 Chronic Lymphocytic Leukemia 4 2023-07-21
FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting

2024-510579-40-00 Rhabdoyosarcoma 9 2020-10-07
Pilot phase II study of Selinexor in combination with Ifosfamide, Etoposide and Dexamethasone (SIDE) in patients with relapsed or refractory… Ended

2024-513295-18-00 Relapsed or Refractory Peripheral T-cell Lymphomas 4 2022-08-10
A study to evaluate KER-050 as a monotherapy or in combination with Ruxolitinib in Myelofibrosis. Ended

2023-507468-38-00 Myelofibrosis 4 2022-04-22
Shortened vs standard chemotherapy combined with immunotherapy for the initial treatment of patients with high tumor burden Follicular Lymph… Ended

2024-511636-27-00 Follicular Lymphoma 5 2021-12-01
The study aims to verify the greater efficacy of the treatment of Acute Lymphoblastic Leukemia Ph + through the combination of Ponatinib and… Ended

2023-508968-30-00 Adult Philadelphia Chromosome-Positive Acute Lymphoblas 5 2021-09-08
The aim of the study is to evaluate the efficacy of Ponatinib, either alone or in combination with chemotherapy, in inducing remission in pa… Ended

2024-516868-28-00 Ph+ Acute Lymphoblastic Leukemia 4 2021-05-04
A Study Evaluating the Safety and Efficacy of Polatuzumab Vedotin in Combination with Rituximab Plus Gemcitabine Plus Oxaliplatin (R- GEMOX)… Ended

2024-512537-33-00 Relapsed/refractory diffuse large B-cell lymphoma (DLBC 5 2019-11-28